CX Institutional’s MetLife MET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $724K | Buy |
8,557
+1,455
| +20% | +$117K | 0.02% | 384 |
|
|
2026
Q1 | $502K | Sell |
7,102
-102,378
| -94% | -$7.66M | 0.02% | 458 |
|
|
2025
Q4 | $8.64M | Buy |
109,480
+13,508
| +14% | +$1.07M | 0.26% | 97 |
|
|
2025
Q3 | $7.91M | Buy |
95,972
+22,285
| +30% | +$1.75M | 0.24% | 104 |
|
|
2025
Q2 | $5.93M | Buy |
73,687
+628
| +0.9% | +$48.5K | 0.21% | 123 |
|
|
2025
Q1 | $5.87M | Buy |
73,059
+5,054
| +7% | +$420K | 0.22% | 103 |
|
|
2024
Q4 | $5.57M | Buy |
68,005
+9,337
| +16% | +$777K | 0.22% | 110 |
|
|
2024
Q3 | $4.84M | Buy |
58,668
+51,370
| +704% | +$3.84M | 0.21% | 130 |
|
|
2024
Q2 | $512K | Buy |
7,298
+1,673
| +30% | +$119K | 0.02% | 368 |
|
|
2024
Q1 | $417K | Buy |
5,625
+229
| +4% | +$16K | 0.02% | 388 |
|
|
2023
Q4 | $357K | Buy |
5,396
+10
| +0.2% | +$626 | 0.02% | 369 |
|
|
2023
Q3 | $339K | Buy |
5,386
+577
| +12% | +$35.9K | 0.02% | 380 |
|
|
2023
Q2 | $272K | Buy |
+4,809
| New | +$267K | 0.01% | 450 |
|
|
2023
Q1 | – | Sell |
-4,366
| Closed | -$316K | – | 541 |
|
|
2022
Q4 | $316K | Buy |
+4,366
| New | +$313K | 0.02% | 424 |
|
|
2022
Q3 | – | Sell |
-2,872
| Closed | -$180K | – | 873 |
|
|
2022
Q2 | $180K | Buy |
+2,872
| New | +$190K | 0.01% | 453 |
|
|
2021
Q4 | – | Sell |
-1,926
| Closed | -$119K | – | 695 |
|
|
2021
Q3 | $119K | Buy |
1,926
+387
| +25% | +$23.3K | 0.01% | 420 |
|
|
2021
Q2 | $92K | Buy |
1,539
+142
| +10% | +$9K | 0.01% | 448 |
|
|
2021
Q1 | $85K | Buy |
1,397
+116
| +9% | +$6.4K | 0.01% | 402 |
|
|
2020
Q4 | $60K | Buy |
1,281
+726
| +131% | +$31.5K | 0.01% | 419 |
|
|
2020
Q3 | $21K | Buy |
555
+122
| +28% | +$4.63K | ﹤0.01% | 536 |
|
|
2020
Q2 | $16K | Sell |
433
-93
| -18% | -$3.24K | ﹤0.01% | 488 |
|
|
2020
Q1 | $16K | Buy |
526
+28
| +6% | +$1.24K | ﹤0.01% | 405 |
|
|
2019
Q4 | $25K | Buy |
498
+45
| +10% | +$2.17K | ﹤0.01% | 327 |
|
|
2019
Q3 | $21K | Sell |
453
-443
| -49% | -$21.1K | ﹤0.01% | 368 |
|
|
2019
Q2 | $45K | Sell |
896
-42,176
| -98% | -$1.98M | 0.01% | 325 |
|
|
2019
Q1 | $1.83M | Buy |
43,072
+42,946
| +34,084% | +$1.9M | 0.32% | 93 |
|
|
2018
Q4 | $5K | Hold |
126
| – | – | ﹤0.01% | 395 |
|
|
2018
Q3 | $6K | Hold |
126
| – | – | ﹤0.01% | 285 |
|
|
2018
Q2 | $5K | Buy |
+126
| New | +$5.87K | ﹤0.01% | 265 |
|
Other funds holding MET
AAMU
WCM
AV
FMII
P
FHC
II
OIAM
CNB
CX Institutional's MET Position: Q2 2026 in Review
CX Institutional increased its MetLife (MET) stake by 20% in Q2 2026, buying an estimated $117K and bringing the position to 8,557 shares worth $724K. The position accounts for 0.02% of the portfolio, ranked #384.
CX Institutional first reported a position in MET in Q2 2018 and has held it in 29 quarters since. The position peaked at $8.64M in Q4 2025. 297 funds tracked by Wall St. Rank hold MET as of Q2 2026.
- CX Institutional held 8,557 shares of MetLife worth $724K as of Q2 2026.
- CX Institutional bought 1,455 MetLife shares in Q2 2026, an estimated $117K.
- MetLife made up 0.02% of CX Institutional's portfolio in Q2 2026, its #384 holding.
- CX Institutional first reported a position in MetLife in Q2 2018 and has held it in 29 quarters since.
- CX Institutional's MetLife position peaked at $8.64M in Q4 2025.
- 297 funds tracked by Wall St. Rank held MetLife as of Q2 2026.
Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.